1. Home
  2. PLAG vs SER Comparison

PLAG vs SER Comparison

Compare PLAG & SER Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Planet Green Holdings Corp.

PLAG

Planet Green Holdings Corp.

N/A

Current Price

$1.69

Market Cap

19.6M

ML Signal

N/A

Logo Serina Therapeutics Inc.

SER

Serina Therapeutics Inc.

HOLD

Current Price

$2.10

Market Cap

19.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PLAG
SER
Founded
1986
2017
Country
United States
United States
Employees
6
13
Industry
Packaged Foods
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Staples
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
19.6M
19.4M
IPO Year
2007
N/A

Fundamental Metrics

Financial Performance
Metric
PLAG
SER
Price
$1.69
$2.10
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$15.00
AVG Volume (30 Days)
10.5K
83.9K
Earning Date
05-14-2026
05-14-2026
Dividend Yield
N/A
N/A
EPS Growth
32.56
N/A
EPS
N/A
N/A
Revenue
$3,040,616.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.80
$1.22
52 Week High
$4.49
$7.92

Technical Indicators

Market Signals
Indicator
PLAG
SER
Relative Strength Index (RSI) 51.79 59.06
Support Level $1.69 $1.75
Resistance Level $1.78 $2.30
Average True Range (ATR) 0.08 0.16
MACD 0.01 0.03
Stochastic Oscillator 70.37 68.96

Price Performance

Historical Comparison
PLAG
SER

About PLAG Planet Green Holdings Corp.

Planet Green Holdings Corp is a diversified technology and consumer products company with a presence in North America and China engaged in Chemical Products, Tea Products, and Online Advertising Services. The company operates in three segments namely to grow, produce, and distribute Cyan brick tea, black tea, and green tea in China; to research, develop, manufacture, and sell chemical products including formaldehyde, urea formaldehyde adhesive, methylal, ethanol fuel, fuel additives and clean fuel in China; and to develop and operate a demand-side platform which empowers buyers of advertising to manage and optimize their digital advertising across different real-time bidding networks in North America and China.

About SER Serina Therapeutics Inc.

Serina Therapeutics Inc is a clinical-stage biotechnology company developing a pipeline of wholly-owned drug product candidates to treat neurological diseases and pain. Serina's POZ Platform delivery technology is engineered to provide control in drug loading and more precision in the rate of release of attached drugs, enabling the potential of certain challenging small molecules, while addressing the limitations of polyethylene glycol (PEG) and other biocompatible polymers. The Company has one reportable segment relating to the research and development of its POZ platform.

Share on Social Networks: